⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CUE News
Cue Biopharma, Inc.
PD-1 Resistant Head and Neck Cancer Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
globenewswire.com
MRK
CUE
Cue Biopharma Announces Pricing of $10 Million Public Offering
globenewswire.com
CUE
Cue Biopharma Announces Proposed Public Offering
globenewswire.com
CUE
Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
globenewswire.com
CUE
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
globenewswire.com
CUE
Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates
globenewswire.com
CUE